Patisiran for the treatment of hereditary transthyretin-mediated amyloidosis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Patisiran for the treatment of hereditary transthyretin-mediated amyloidosis
Authors
Keywords
-
Journal
Expert Review of Clinical Pharmacology
Volume -, Issue -, Pages 1-5
Publisher
Informa UK Limited
Online
2019-01-16
DOI
10.1080/17512433.2019.1567326
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cerebrospinal fluid and vitreous body exposure to orally administered tafamidis in hereditary ATTRV30M (p.TTRV50M) amyloidosis patients
- (2018) Cecilia Monteiro et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Inhibition of the Amyloidogenesis of Transthyretin by Natural Products and Synthetic Compounds
- (2018) Takeshi Yokoyama et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Family dynamics in transthyretin-related familial amyloid polyneuropathy Val30Met: does genetic risk affect family functioning?
- (2018) Alice Lopes et al. CLINICAL GENETICS
- The genetic heterogeneity of hereditary transthyretin amyloidosis in a sample of the Brazilian population
- (2018) Carolina Lavigne-Moreira et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
- (2018) Merrill D. Benson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oligonucleotide Drugs for Transthyretin Amyloidosis
- (2018) Joel N. Buxbaum NEW ENGLAND JOURNAL OF MEDICINE
- Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility
- (2018) Jayesh A. Kulkarni et al. Nucleic Acid Therapeutics
- Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial
- (2018) Marcia Waddington-Cruz et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Inotersen: First Global Approval
- (2018) Susan J. Keam DRUGS
- Widespread Cardiac and Vasomotor Autonomic Dysfunction in Non-Val30Met Hereditary Transthyretin Amyloidosis
- (2018) Haruki Koike et al. INTERNAL MEDICINE
- The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market
- (2017) Ricardo Titze-de-Almeida et al. PHARMACEUTICAL RESEARCH
- Liver transplantation in transthyretin amyloidosis: Characteristics and management related to kidney disease
- (2017) Ana Rocha et al. Transplantation Reviews
- Efficiency of silencing RNA for removal of transthyretin V30M in a TTR leptomeningeal animal model
- (2016) Paula Gonçalves et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis
- (2016) James S. Butler et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Current and Future Treatment Approaches in Transthyretin Familial Amyloid Polyneuropathy
- (2016) Philippe Kerschen et al. Current Treatment Options in Neurology
- TTR kinetic stabilizers and TTR gene silencing: a new era in therapy for familial amyloidotic polyneuropathies
- (2016) David Adams et al. EXPERT OPINION ON PHARMACOTHERAPY
- Evolving landscape in the management of transthyretin amyloidosis
- (2015) Philip N. Hawkins et al. ANNALS OF MEDICINE
- Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study
- (2015) Ole B Suhr et al. Orphanet Journal of Rare Diseases
- Drugging RNAi
- (2015) D. Haussecker et al. SCIENCE
- Liver Transplantation for Hereditary Transthyretin Amyloidosis
- (2015) Bo-Göran Ericzon et al. TRANSPLANTATION
- Repurposing Diflunisal for Familial Amyloid Polyneuropathy
- (2015) John L. Berk et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings
- (2014) L. F. Maia et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis
- (2013) Teresa Coelho et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guideline of transthyretin-related hereditary amyloidosis for clinicians
- (2013) Yukio Ando et al. Orphanet Journal of Rare Diseases
- Transthyretin (TTR) Cardiac Amyloidosis
- (2012) Frederick L. Ruberg et al. CIRCULATION
- Cardiac transthyretin amyloidosis
- (2012) Jason N Dungu et al. HEART
- The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to Pathology to a Regulatory-Agency-Approved Drug
- (2012) Steven M. Johnson et al. JOURNAL OF MOLECULAR BIOLOGY
- Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial
- (2012) T. Coelho et al. NEUROLOGY
- Familial amyloid polyneuropathy
- (2011) Violaine Planté-Bordeneuve et al. LANCET NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now